Clinical Insights on CBD Metabolic Effects from Epidiolex Trials
Clinical trial participants using FDA-approved CBD (Epidiolex) experienced notable metabolic effects, including weight gain. These findings highlight the importance of monitoring metabolic changes in patients prescribed Epidiolex. Understanding CBD…
FDA-Approved CBD Drug Shows Early Promise in Anorexia Patients
Emerging research on the FDA approved CBD drug anorexia treatment shows early promise in patients. This study highlights potential benefits in appetite regulation and anxiety reduction. Further clinical trials are needed to confirm efficacy and safety.
Fitch Affirms Jazz’s IDR at ‘BB’; Outlook Stable
Credit rating stability pharmaceutical cannabis is crucial for maintaining access to Epidiolex, the FDA-approved cannabidiol medication for pediatric epilepsy. Fitch Ratings affirmed Jazz Pharmaceuticals' credit rating at 'BB' with a stable outlook,…
